Salvador Plasencia Pleads Guilty in Matthew Perry Ketamine Death
Analysis based on 24 articles · First reported Jul 23, 2025 · Last updated Jul 23, 2025
The event highlights the risks associated with the rapidly growing at-home Ketamine industry, potentially leading to stricter oversight and clear protocols for medical professionals. This could impact pharmaceutical companies involved in Ketamine production and distribution, as well as healthcare providers offering such treatments.
Dr. Salvador Plasencia pleaded guilty to four counts of distributing Ketamine to actor Matthew Perry in the month leading up to Perry's overdose death in October 2023. Plasencia, one of five people charged in connection with Perry's death, admitted to illegally supplying 20 vials of Ketamine, lozenges, and syringes to Perry. He faces a maximum sentence of 40 years in prison and will surrender his medical license. Prosecutors stated that Plasencia did not sell Perry the lethal dose, which is alleged to have been supplied by Jasveen Sangha, known as the 'Ketamine Queen,' who has pleaded not guilty. Other co-defendants, including Matthew Perry's assistant Kenneth Iwamasa and another doctor Adema, have also pleaded guilty. The case has brought attention to the dangers of unregulated Ketamine distribution and the need for stricter oversight in the at-home Ketamine industry.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard